238 related articles for article (PubMed ID: 33853794)
1. Estimation of overdiagnosis in colorectal cancer screening with sigmoidoscopy and faecal occult blood testing: comparison of simulation models.
Wieszczy P; Kaminski MF; Løberg M; Bugajski M; Bretthauer M; Kalager M
BMJ Open; 2021 Apr; 11(4):e042158. PubMed ID: 33853794
[TBL] [Abstract][Full Text] [Related]
2. Modeling in Colorectal Cancer Screening: Assessing External and Predictive Validity of MISCAN-Colon Microsimulation Model Using NORCCAP Trial Results.
Buskermolen M; Gini A; Naber SK; Toes-Zoutendijk E; de Koning HJ; Lansdorp-Vogelaar I
Med Decis Making; 2018 Nov; 38(8):917-929. PubMed ID: 30343626
[TBL] [Abstract][Full Text] [Related]
3. Options for screening for colorectal cancer.
Atkin W
Scand J Gastroenterol Suppl; 2003; (237):13-6. PubMed ID: 12797674
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study.
Buskermolen M; Cenin DR; Helsingen LM; Guyatt G; Vandvik PO; Haug U; Bretthauer M; Lansdorp-Vogelaar I
BMJ; 2019 Oct; 367():l5383. PubMed ID: 31578177
[TBL] [Abstract][Full Text] [Related]
5. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
[TBL] [Abstract][Full Text] [Related]
6. Number of Adenomas Removed and Colorectal Cancers Prevented in Randomized Trials of Flexible Sigmoidoscopy Screening.
Pinsky PF; Loberg M; Senore C; Wooldrage K; Atkin W; Bretthauer M; Cross AJ; Hoff G; Holme O; Kalager M; Segnan N; Schoen RE
Gastroenterology; 2018 Oct; 155(4):1059-1068.e2. PubMed ID: 29935150
[TBL] [Abstract][Full Text] [Related]
7. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.
Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Schneede J; Tveit KM; Hoff G
JAMA; 2014 Aug; 312(6):606-15. PubMed ID: 25117129
[TBL] [Abstract][Full Text] [Related]
8. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years.
Gondal G; Grotmol T; Hofstad B; Bretthauer M; Eide TJ; Hoff G
Scand J Gastroenterol; 2003 Jun; 38(6):635-42. PubMed ID: 12825872
[TBL] [Abstract][Full Text] [Related]
9. Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention).
Bretthauer M; Gondal G; Larsen K; Carlsen E; Eide TJ; Grotmol T; Skovlund E; Tveit KM; Vatn MH; Hoff G
Scand J Gastroenterol; 2002 May; 37(5):568-73. PubMed ID: 12059059
[TBL] [Abstract][Full Text] [Related]
10. Screening for colorectal cancer using the faecal occult blood test, Hemoccult.
Hewitson P; Glasziou P; Irwig L; Towler B; Watson E
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001216. PubMed ID: 17253456
[TBL] [Abstract][Full Text] [Related]
11. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals.
Holme Ø; Bretthauer M; Fretheim A; Odgaard-Jensen J; Hoff G
Cochrane Database Syst Rev; 2013 Oct; 2013(9):CD009259. PubMed ID: 24085634
[TBL] [Abstract][Full Text] [Related]
12. What is the best screening strategy to detect advanced colorectal adenomas? Simulation from ongoing Italian screening experiences.
Ventura L; Zappa M; Carreras G; Ciatto S; Grazzini G
Tumori; 2011; 97(5):547-50. PubMed ID: 22158481
[TBL] [Abstract][Full Text] [Related]
13. Association between use of low-dose aspirin and detection of colorectal polyps and cancer in a screening setting.
Nafisi S; Randel KR; Støer NC; Veierød MB; Hoff G; Holme Ø; Schult AL; Botteri E
Dig Liver Dis; 2023 Aug; 55(8):1126-1132. PubMed ID: 36754644
[TBL] [Abstract][Full Text] [Related]
14. Current status of screening for colorectal cancer.
Garborg K; Holme Ø; Løberg M; Kalager M; Adami HO; Bretthauer M
Ann Oncol; 2013 Aug; 24(8):1963-72. PubMed ID: 23619033
[TBL] [Abstract][Full Text] [Related]
15. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up.
Scholefield JH; Moss SM; Mangham CM; Whynes DK; Hardcastle JD
Gut; 2012 Jul; 61(7):1036-40. PubMed ID: 22052062
[TBL] [Abstract][Full Text] [Related]
16. [Prevention and early diagnosis of colorectal cancer].
Bretthauer M; Hoff G
Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2688-91. PubMed ID: 17952153
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial.
Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Lekven J; Schneede J; Tveit KM; Vatn M; Ursin G; Hoff G;
Ann Intern Med; 2018 Jun; 168(11):775-782. PubMed ID: 29710125
[TBL] [Abstract][Full Text] [Related]
18. Mortality From Postscreening (Interval) Colorectal Cancers Is Comparable to That From Cancer in Unscreened Patients-A Randomized Sigmoidoscopy Trial.
Jodal HC; Løberg M; Holme Ø; Adami HO; Bretthauer M; Emilsson L; Ransohoff DF; Hoff G; Kalager M
Gastroenterology; 2018 Dec; 155(6):1787-1794.e3. PubMed ID: 30165051
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
20. Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies.
Castells A; Bessa X; Quintero E; Bujanda L; Cubiella J; Salas D; Lanas A; Carballo F; Morillas JD; Hernández C; Jover R; Montalvo I; Arenas J; Cosme A; Hernández V; Iglesias B; Castro I; Cid L; Sala T; Ponce M; Andrés M; Teruel G; Peris A; Roncales MP; González-Rubio F; Seoane-Urgorri A; Grau J; Serradesanferm A; Pellisé M; Ono A; Cruzado J; Pérez-Riquelme F; Alonso-Abreu I; Carrillo-Palau M; de la Vega-Prieto M; Iglesias R; Amador J; Blanco JM; Sastre R; Ferrándiz J; González-Hernández MJ; Andreu M;
J Natl Cancer Inst; 2013 Jun; 105(12):878-86. PubMed ID: 23708054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
